News
Zacks.com on MSN3d
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback